These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 16835227

  • 1. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
    Yang S, Jeong JH, Brown AL, Lee CH, Pandolfi PP, Chung JH, Kim MK.
    J Biol Chem; 2006 Sep 08; 281(36):26645-54. PubMed ID: 16835227
    [Abstract] [Full Text] [Related]

  • 2. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D, Hartmann JU, Wurm AA, Gerloff D, Katzerke C, Verga Falzacappa MV, Pelicci PG, Müller-Tidow C, Tenen DG, Niederwieser D, Behre G.
    Cancer Res; 2015 Aug 15; 75(16):3411-24. PubMed ID: 26041820
    [Abstract] [Full Text] [Related]

  • 3. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
    Joe Y, Jeong JH, Yang S, Kang H, Motoyama N, Pandolfi PP, Chung JH, Kim MK.
    J Biol Chem; 2006 Sep 29; 281(39):28764-71. PubMed ID: 16891316
    [Abstract] [Full Text] [Related]

  • 4. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
    di Masi A, Cilli D, Berardinelli F, Talarico A, Pallavicini I, Pennisi R, Leone S, Antoccia A, Noguera NI, Lo-Coco F, Ascenzi P, Minucci S, Nervi C.
    Cell Death Dis; 2016 Jul 28; 7(7):e2308. PubMed ID: 27468685
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A, Toyoshima K, Watanabe Y, Onishi N, Hazaka Y, Tsukuda Y, Tsukada J, Kondo T, Tanaka Y, Minami Y.
    J Biol Chem; 2008 Jul 04; 283(27):18969-79. PubMed ID: 18482988
    [Abstract] [Full Text] [Related]

  • 6. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A.
    Blood; 1998 Apr 15; 91(8):2634-42. PubMed ID: 9531570
    [Abstract] [Full Text] [Related]

  • 7. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K, Wang F, Cao WB, Lv XX, Hua F, Cui B, Yu JJ, Zhang XW, Shang S, Liu SS, Yu JM, Han MZ, Huang B, Zhang TT, Li X, Jiang JD, Hu ZW.
    Cancer Cell; 2017 May 08; 31(5):697-710.e7. PubMed ID: 28486108
    [Abstract] [Full Text] [Related]

  • 8. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.
    Isakson P, Bjørås M, Bøe SO, Simonsen A.
    Blood; 2010 Sep 30; 116(13):2324-31. PubMed ID: 20574048
    [Abstract] [Full Text] [Related]

  • 9. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S, Kuo C, Bisi JE, Kim MK.
    Nat Cell Biol; 2002 Nov 30; 4(11):865-70. PubMed ID: 12402044
    [Abstract] [Full Text] [Related]

  • 10. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP.
    Nat Genet; 1998 Feb 30; 18(2):126-35. PubMed ID: 9462740
    [Abstract] [Full Text] [Related]

  • 11. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.
    Ablain J, Rice K, Soilihi H, de Reynies A, Minucci S, de Thé H.
    Nat Med; 2014 Feb 30; 20(2):167-74. PubMed ID: 24412926
    [Abstract] [Full Text] [Related]

  • 12. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.
    Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078
    [Abstract] [Full Text] [Related]

  • 13. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
    Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P.
    Blood; 1998 Sep 01; 92(5):1758-67. PubMed ID: 9716606
    [Abstract] [Full Text] [Related]

  • 14. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
    Nervi C, Ferrara FF, Fanelli M, Rippo MR, Tomassini B, Ferrucci PF, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci PG, Testi R.
    Blood; 1998 Oct 01; 92(7):2244-51. PubMed ID: 9746761
    [Abstract] [Full Text] [Related]

  • 15. HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse.
    Coltella N, Percio S, Valsecchi R, Cuttano R, Guarnerio J, Ponzoni M, Pandolfi PP, Melillo G, Pattini L, Bernardi R.
    EMBO Mol Med; 2014 May 01; 6(5):640-50. PubMed ID: 24711541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH, Liu CC, Yen CC, Gau JP, Wang WS, Tzeng CH.
    Int J Cancer; 2009 Jul 01; 125(1):71-7. PubMed ID: 19291793
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope.
    Séror C, Raza SQ, Brottes F, Subra F, Piacentini M, Perfettini JL, Kroemer G.
    Cell Cycle; 2009 Feb 01; 8(3):438-42. PubMed ID: 19177012
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.